Marek Wagner
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- Immune cells in cancer
- Oncology top 10%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- IL-33, ST2, and ILC Pathways 11
- Immune Cell Function and Interaction 9
- Immune cells in cancer 4
- Oncology 11
- Lymphatic System and Diseases 7
- Cancer Cells and Metastasis 4
- Co-authors
- Helge Wiig (13 shared papers)Shigeo Koyasu (10 shared papers)Andrew C. Dudley (3 shared papers)Rolf Bjerkvig (5 shared papers)Hans Petter Eikesdal (3 shared papers)Kari K. Alitalo (2 shared papers)Kazuyo Moro (2 shared papers)Stefani Spranger (1 shared paper)
In The Last Decade
Marek Wagner
31 papers receiving 833 citations
Peers
Comparison fields: 5 of 78
- Immunology 310
- Oncology 336
- Cancer Research 86
- Molecular Biology 251
- Physiology 89
Countries citing papers authored by Marek Wagner
This map shows the geographic impact of Marek Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Wagner more than expected).
Fields of papers citing papers by Marek Wagner
This network shows the impact of papers produced by Marek Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Wagner. The network helps show where Marek Wagner may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 169 | |
| 2 | 2015 | 92 | |
| 3 | 2012 | 71 | |
| 4 | 2020 | 63 | |
| 5 | 2015 | 51 | |
| 6 | 2019 | 42 | |
| 7 | 2014 | 37 | |
| 8 | 2009 | 34 | |
| 9 | 2019 | 29 | |
| 10 | 2017 | 28 | |
| 11 | 2013 | 26 | |
| 12 | 2013 | 25 | |
| 13 | 2016 | 24 | |
| 14 | 2013 | 23 | |
| 15 | 2012 | 20 | |
| 16 | A dangerous duo in adipose tissue: high-mobility group box 1 protein and macrophages. | 2014 | 15 |
| 17 | 2017 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2025 | 8 |
About Marek Wagner
Marek Wagner is a scholar working on Immunology, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 33 papers that have together received 841 indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (11 papers), Immune Cell Function and Interaction (9 papers), Lymphatic System and Diseases (7 papers), Eosinophilic Esophagitis (5 papers), Immune cells in cancer (4 papers), Cancer Cells and Metastasis (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Immunology (310 citations), Oncology (336 citations), Cancer Research (86 citations), Molecular Biology (251 citations) and Physiology (89 citations). Marek Wagner has collaborated with scholars based in Norway, Japan and Poland. Frequent co-authors include Helge Wiig, Shigeo Koyasu, Andrew C. Dudley, Rolf Bjerkvig, Hans Petter Eikesdal, Kari K. Alitalo, Kazuyo Moro, Stefani Spranger, Amanda W. Lund and Manuel Fankhauser. Their work appears in journals such as Frontiers in Immunology, Expert Opinion on Therapeutic Targets, Arteriosclerosis Thrombosis and Vascular Biology, Trends in Immunology and Trends in cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.